Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [123I]β-CIT

This publication has 58 references indexed in Scilit:

• Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin 1A receptors
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999
• [3H]WAY–100635 for 5–HT1A receptor autoradiography in human brain: a comparison with [3H]8–OH–DPAT and demonstration of increased binding in the frontal cortex in schizophrenia
  Neurochemistry International, 1997
• Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
  Proceedings of the National Academy of Sciences, 1997
• The role of serotonin in the pathophysiology and treatment of schizophrenia
  The Journal of Neuropsychiatry and Clinical Neurosciences, 1997
• 5-HT1A and 5-HT2A Receptor mRNAs and Binding Site Densities Are Differentially Altered in Schizophrenia
  Neuropsychopharmacology, 1996
• Evaluation of the monoamine uptake site ligand [131I]methyl 3β-(4-Iodophenyl)-tropane-2β-carboxylate ([123I]β-CIT) in non-human primates: Pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI
  Nuclear Medicine and Biology, 1993
• [125I]RTI-55: a potent ligand for dopamine transporters
  European Journal of Pharmacology, 1991
• Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs
  Psychopharmacology, 1990
• CNS stimulants as tools in the study of schizophrenia
  Trends in Neurosciences, 1984
• Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain
  Acta Pharmacologica et Toxicologica, 1963